Related Experiment Video
Updated: Sep 28, 2025

Technical Aspects of the Mouse Aortocaval Fistula
Published on: July 11, 2013
Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients:
Tania Salehi1,2, Nicholas J Montarello2,3, Nishant Juneja3
1Central Northern Adelaide Renal and Transplantation Service, Adelaide, South Australia, Australia.
Insights
Arteriovenous fistula (AVF) ligation after kidney transplant significantly reduces left ventricular mass long-term. This cardiovascular benefit may decrease mortality risk in kidney transplant recipients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- The long-term impact of arteriovenous fistula (AVF) ligation on cardiovascular structure post-kidney transplantation is not well-established.
- A prior randomized controlled trial (RCT) indicated AVF ligation at 6 months post-transplant reduced left ventricular mass (LVM).
- This study aimed to assess the sustained effects of AVF ligation on cardiovascular parameters.
Purpose of the Study:
- To evaluate the long-term evolution of cardiovascular magnetic resonance imaging (CMR)-derived parameters after AVF ligation in kidney transplant recipients.
- To compare cardiovascular structure at long-term follow-up with measurements taken 6 months post-AVF ligation.
Main Methods:
- A long-term follow-up observational cohort study was conducted on patients from a previous RCT.
- Cardiovascular magnetic resonance imaging (CMR) was performed at a median of 5.1 years post-AVF ligation.
- Changes in left ventricular mass (LVM) and LVM index were compared to 6-month post-intervention measurements.
Main Results:
- At a median of 5.1 years, statistically significant further reductions in LVM (-17.6±23.0 g, P=0.006) and LVM index (-10.0±13.0 g/m², P=0.006) were observed.
- These findings indicate a persistent effect of AVF ligation on cardiac remodeling.
Conclusions:
- The cardiovascular benefits of AVF ligation, specifically LVM and LVM index regression, appear to be sustained over the long term.
- Continued reduction in cardiac remodeling post-AVF ligation holds potential for significantly decreasing cardiovascular mortality in kidney transplant patients.
Background:
The long-term effects of arteriovenous fistula (AVF) ligation on cardiovascular structure following kidney transplantation remain uncertain. A prospective randomized, controlled trial (RCT) examined the effect of AVF ligation at 6 months on cardiovascular magnetic resonance imaging (CMR)-derived parameters in 27 kidney transplant recipients compared with 27 controls. A mean decrease in left ventricular mass (LVM) of 22.1 g (95% CI, 15.0 to 29.1) was observed compared with an increase of 1.2 g (95% CI, -4.8 to 7.2) in the control group (P<0.001). We conducted a long-term follow-up observational cohort study in the treated cohort to determine the evolution of CMR-derived parameters compared with those documented at 6 months post-AVF ligation.
Methods:
We performed CMR at long-term follow-up in the AVF ligation observational cohort from our original RCT published in 2019. Results were compared with CMR at 6 months postintervention. The coprimary end point was the change in CMR-derived LVM and LVM index at long-term follow-up from imaging at 6 months postindex procedure.
Results:
At a median of 5.1 years (interquartile range, 4.7-5.5 years), 17 patients in the AVF ligation group were studied with repeat CMR with a median duration to follow-up imaging of 5.1 years (IQR, 4.7-5.5 years). Statistically significant further reductions in LVM (-17.6±23.0 g, P=0.006) and LVM index (-10.0±13.0 g/m2, P=0.006) were documented.
Conclusions:
The benefit of AVF ligation on LVM and LVM index regression appears to persist long term. This has the potential to lead to a significant reduction in cardiovascular mortality.
Related Concept Videos
Hemodialysis I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

